Market Value2,027,191,000
Total Holdings65
File Date2017-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FOLD / Amicus Therapeutics, Inc.
LUMO / Lumos Pharma, Inc.
EHTH / eHealth, Inc.
INSM / Insmed Incorporated
PBYI / Puma Biotechnology, Inc. Call
/ Array BioPharma, Inc.
MOH / Molina Healthcare, Inc.
FATE / Fate Therapeutics, Inc.
CNC / Centene Corporation
ELV / Elevance Health, Inc.
CMRX / Chimerix, Inc.
NXTM / NxStage Medical, Inc.
AMED / Amedisys, Inc.
MODN / Model N, Inc.
BOLD / Boundless Bio, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
JNCE / Jounce Therapeutics Inc
LJPC / La Jolla Pharmaceutical Co.
SPNC / Spectranetics Corp. (The)
NKTR / Nektar Therapeutics
CASC / Cascadian Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
NSTG / NanoString Technologies, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
GWP / GW Pharmaceuticals plc
WVE / Wave Life Sciences Ltd.
EPZM / Epizyme Inc
HOLX / Hologic, Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
SYRS / Syros Pharmaceuticals, Inc.
TFX / Teleflex Incorporated
JUNO / Juno Therapeutics, Inc.
PBYI / Puma Biotechnology, Inc.
SHPG / Shire Plc.
LHCG / LHC Group Inc
XNCR / Xencor, Inc.
US69354M1080 / PRA Health Sciences Inc
NITE / Capitol Series Trust - The Nightview Fund
PETQ / PetIQ, Inc.
CBAY / CymaBay Therapeutics, Inc.
EW / Edwards Lifesciences Corporation
ACRS / Aclaris Therapeutics, Inc.
US29266S3040 / Endologix, Inc.
DPLO / Diplomat Pharmacy, Inc.
MEDP / Medpace Holdings, Inc.
SYNH / Syneos Health Inc - Class A
LIFE / aTyr Pharma, Inc.
AET / Aetna, Inc.
/ Oxford Immunotec Global PLC
CSLT / Castlight Health Inc - Class B
LIVN / LivaNova PLC
PRQR / ProQR Therapeutics N.V.
ADVM / Adverum Biotechnologies, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
NDRM / NeuroDerm Ltd.
GLYC / GlycoMimetics, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
OVID / Ovid Therapeutics Inc.
BKD / Brookdale Senior Living Inc.
AGIO / Agios Pharmaceuticals, Inc.
CLVS / Clovis Oncology Inc Call
018490100 / Allergan plc
PRTA / Prothena Corporation plc
SGEN / Seagen Inc
ICUI / ICU Medical, Inc.
GBT / Global Blood Therapeutics Inc.
UNH / UnitedHealth Group Incorporated
DCPH / Deciphera Pharmaceuticals, Inc.
IRTC / iRhythm Technologies, Inc.
BPMC / Blueprint Medicines Corporation
ATRA / Atara Biotherapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
IMGN / ImmunoGen, Inc.
CLVS / Clovis Oncology Inc
BSX / Boston Scientific Corporation
NVTA / Invitae Corporation
PEN / Penumbra, Inc.
CTLT / Catalent, Inc.
RGNX / REGENXBIO Inc.